On this page
MESP2
mesoderm posterior bHLH transcription factor 2
The MESP2 gene provides instructions for a protein critical in early embryonic development, specifically in forming the bones of the spine through a process called somite segmentation. MESP2 encodes a transcription factor essential for the proper formation and separation of future vertebrae during embryonic development.
MESP2 is located on the long (q) arm of chromosome 15, at band 15q26.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 15 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MESP2 gene, also known as mesoderm posterior bHLH transcription factor 2, is fundamental for human embryonic development. It provides the blueprint for a protein that acts as a transcription factor, meaning it controls the activity of other genes. Specifically, MESP2 is vital for the correct formation of the spinal column and ribs, particularly through its involvement in somite segmentation.
Dysregulation of MESP2 can lead to developmental disorders characterised by abnormalities in the spine and ribs. Understanding the role of MESP2 is important for comprehending the genetic basis of these conditions and for advancing diagnostic approaches.
What the gene does
The MESP2 protein functions as a transcription factor, binding to specific DNA regions to regulate gene expression. It is a crucial component of the Notch signalling pathway, which is integral to embryonic development. The Notch pathway, along with the MESP2 protein, is involved in somite segmentation, a complex process where future vertebrae separate from one another.
During this process, the activity of MESP2 and other Notch pathway proteins oscillates in a specific pattern to ensure proper segmentation. The MESP2 protein modulates Notch activity by activating genes within the pathway, which in turn helps to repress the NOTCH1 protein's function. Additionally, MESP2 appears to play a role in marking the boundaries between future vertebrae, although the precise mechanisms for this are still being investigated. Its role in regulating gene activity is therefore central to the organised development of the axial skeleton.
Video: Genetics 101
Chromosome location
The MESP2 gene is situated on chromosome 15 at position 15q26.1. This genomic location indicates its specific address within the human genome. Its precise placement is relevant for genetic studies and understanding its inheritance patterns in various conditions.
Protein structure
The MESP2 protein is composed of 397 amino acids. It contains several distinct regions that contribute to its function. Two disordered regions are found at amino acids 28-92 and 152-208. A basic helix-loop-helix (bHLH) domain, characteristic of transcription factors, is located between amino acids 81 and 135. Furthermore, the protein features a region with 13 tandem repeats of G-Q dipeptides (13 X 2 AA tandem repeats of G-Q) from amino acids 179-204, which includes individual repeats denoted 1 through 13.
Key variants
Genetic variations within the MESP2 gene can include changes that affect the protein's structure and function. These changes can range from single amino acid substitutions to larger alterations that impact gene expression or protein stability. Such variations may disrupt the critical developmental processes that MESP2 regulates, leading to various health conditions. The inheritance pattern for MESP2-related conditions can vary depending on the specific genetic change.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.116C>A | p.Ser39Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
c.11C>A | p.Ser4Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Inborn genetic diseases |
c.125C>A | p.Ser42Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
c.229G>T | p.Gly77Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
c.83G>A | p.Trp28Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
g.(?_90319589)_(90321565_?)del | - | Pathogenic | ★☆☆☆ | not provided |
c.146_161dup | p.Gln55fs | Pathogenic | ★☆☆☆ | not provided |
c.413del | p.Val138fs | Pathogenic | ★☆☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
c.427G>T | p.Glu143Ter | Pathogenic | ★☆☆☆ | not provided |
c.463del | p.Asp155fs | Pathogenic | ★☆☆☆ | Spondylocostal dysostosis 2, autosomal recessive |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variations in the MESP2 gene are associated with several inherited conditions that primarily affect the development of the spine and ribs. These include Spondylocostal dysostosis and Spondylothoracic dysostosis. Both conditions are characterised by abnormalities in the formation of the vertebral column and ribs, leading to skeletal malformations and potential complications related to chest cavity development. At least three mutations in the MESP2 gene have been identified as causes of spondylothoracic dysostosis, all of which involve the replacement of a single amino acid in the protein sequence.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The MESP2 gene is included on several NHS Genomic Medicine Service national test directories in the UK. It is listed as 'green' on the DDG2P (Developmental Disorders Genotyping Panel), Foetal anomalies (R21) panel, and Skeletal dysplasia (R104) panel. This indicates that MESP2 is considered a gene where variations are established to cause relevant conditions, and it is routinely tested for within these clinical contexts.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the MESP2 gene?
The MESP2 gene provides instructions for a transcription factor protein that is essential for the development and segmentation of the spinal column and ribs during early embryonic stages. It regulates the activity of other genes within the Notch signalling pathway.
What health conditions are associated with MESP2 gene variations?
Variations in the MESP2 gene are primarily associated with inherited conditions affecting spinal and rib development, including Spondylocostal dysostosis and Spondylothoracic dysostosis. These conditions lead to skeletal malformations.
How does MESP2 contribute to spinal development?
MESP2 plays a critical role in somite segmentation, a process where precursor cells for future vertebrae separate from each other. It works within the Notch pathway to activate specific genes and help define the boundaries of developing vertebrae.
References
- Sasaki N, Kiso M, Kitagawa M. The repression of Notch signaling occurs via the destabilization of mastermind-like 1 by Mesp2 and is essential for somitogenesis. Development (Cambridge, England). 2011. PMID: 21098559
- Oginuma M, Takahashi Y, Kitajima S. The oscillation of Notch activation, but not its boundary, is required for somite border formation and rostral-caudal patterning within a somite. Development (Cambridge, England). 2010. PMID: 20335362
- Gibb S, Maroto M, Dale JK. The segmentation clock mechanism moves up a notch. Trends in cell biology. 2010. PMID: 20724159
- Ferjentsik Z, Hayashi S, Dale JK. Notch is a critical component of the mouse somitogenesis oscillator and is essential for the formation of the somites. PLoS genetics. 2009. PMID: 19779553
- Cornier AS, Staehling-Hampton K, Delventhal KM. Mutations in the MESP2 gene cause spondylothoracic dysostosis/Jarcho-Levin syndrome. American journal of human genetics. 2008. PMID: 18485326
- Sparrow DB, Chapman G, Turnpenny PD. Disruption of the somitic molecular clock causes abnormal vertebral segmentation. Birth defects research. Part C, Embryo today : reviews. 2007. PMID: 17600782
- Morimoto M, Takahashi Y, Endo M. The Mesp2 transcription factor establishes segmental borders by suppressing Notch activity. Nature. 2005. PMID: 15902259
- Whittock NV, Sparrow DB, Wouters MA. Mutated MESP2 causes spondylocostal dysostosis in humans. American journal of human genetics. 2004. PMID: 15122512
- Adam MP, Bick S, Mirzaa GM. Spondylocostal Dysostosis, Autosomal Recessive. 1993. PMID: 20301771